If this research continues to pan out, scientists may be able to provide lasting protection against other diseases like hepatitis C, flu, and covid-19.
in 2018 and is part of a large collaboration between scientists at Scripps, the National Institutes of Health, the Fred Hutchinson Cancer Center, and other groups in the U.S. and Sweden. It involved 48 healthy participants, 36 of whom were given two doses of the vaccine eight weeks apart .
HIV infection can be now effectively managed through lifelong antiviral therapy. But the virus has the ability to craftily change its structure once inside the body, making it hard for the immune system to recognize it for long. This means that sustained immunity to the virus, at least in most cases, has remained out of reach. But we’ve known for decades that some people can produce broadly neutralizing antibodies to the virus that can keep up with it.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
New Experimental HIV Vaccine Shows Promise in Early Human TrialsAn HIV vaccine candidate is showing positive early results, prompting a critical component of the human immune response in 97 percent of vaccine recipients.
Leer más »
HIV vaccine candidate shows early promiseThe vaccine, called eOD-GT8 60mer, had a “favorable safety profile” and induced broadly neutralizing antibodies in 97%, or all but one, of the 36 recipients, according to the researcher…
Leer más »
Vaccine prompts HIV antibodies in 97 per cent of people in small studyAn experimental HIV vaccine led to antibodies against the virus in 35 out of 36 volunteers, but whether this offers protection against the infection is unclear
Leer más »
Breakthrough HIV vaccine triumphs in phase 1 clinical trialThe vaccine triggers neutralizing antibodies that can induce immune responses against HIV infection.
Leer más »
Scientists Hopeful About Promising Results From HIV VaccineAn experimental HIV vaccine has intrigued scientists after they found it was able to generate antibodies against the deadly virus in 35 out of 36 people.
Leer más »
HIV vaccine candidate induces immune response in early clinical trial: 'An important step forward' | CNNAn experimental HIV vaccine has been found to induce broadly neutralizing antibodies among a small group of volunteers in a Phase 1 study. The findings suggest that a two-dose regimen of the vaccine, given eight weeks apart, can elicit immune responses against the human immunodeficiency virus.
Leer más »